Dr. Michelle Uttaburanont, MD

Dr. Uttaburanont practices at Platinum Women's Health and Wellness in Temecula, California.

Dr. Uttaburanont's NPI, 1528297918, was assigned on July 7, 2009. Dr. Uttaburanont holds California license A125726.

Dr. Uttaburanont's primary practice is Platinum Women's Health and Wellness, at 28780 Single Oak Dr, Temecula, CA 92590 in Riverside County. The practice phone is (951) 676-4193.

Dr. Uttaburanont's primary practice is Platinum Women's Health and Wellness in Temecula, California. The medical group on file is Rancho Family Medical Group. Dmand AI also links Dr. Uttaburanont to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uttaburanont practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Uttaburanont's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Uttaburanont is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Uttaburanont's licenses on file in 2 states: California and Michigan.

Dmand AI lists acid reflux, acute kidney failure, aneurysm, aortic atherosclerois, asthma, atrial fibrillation and flutter, benign or precancerous skin growths and cardiomyopathy among the conditions Dr. Uttaburanont treats.

CMS data shows 645 Medicare services from Dr. Uttaburanont across 9 procedure codes in 2024, for 359 Medicare patients. Medicare paid $53,780 for them. Every service was in an office.

CMS counts 359 Medicare patients who saw Dr. Uttaburanont in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Uttaburanont's median patient age at 65, with 71% women.

In 2024, Dr. Uttaburanont wrote 8,938 Medicare Part D claims for 896 patients. 88% of them were for generic drugs. CMS names the drug for 8,053 of them, across 119 drugs with 11 or more claims each, at $614,033 in total drug cost. In 2023, CMS named 7,252 claims across 116 drugs.

Dr. Uttaburanont accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Uttaburanont as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Uttaburanont in 2020. 2020 was the busiest year, with 2. Dr. Uttaburanont's most frequent co-authors are Maciej Witkos, MD, Christine Phuong Pham, DO and Karan Pratap Singh.

CMS Open Payments shows 154 general payments to Dr. Uttaburanont from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $498.

Dr. Uttaburanont is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.